Charmacy Pharmaceutical Co., Ltd. (HKG:2289)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.80
-0.08 (-1.36%)
Jan 30, 2026, 3:55 PM HKT
-26.30%
Market Cap 626.40M
Revenue (ttm) 4.65B
Net Income (ttm) 52.90M
Shares Out 108.00M
EPS (ttm) 0.49
PE Ratio 11.84
Forward PE n/a
Dividend 0.49 (8.43%)
Ex-Dividend Date May 26, 2025
Volume 6,000
Average Volume n/a
Open 5.80
Previous Close 5.88
Day's Range 5.80 - 5.88
52-Week Range 4.30 - 7.88
Beta -1.02
RSI 28.53
Earnings Date Mar 27, 2026

About Charmacy Pharmaceutical

Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business in the People’s Republic of China. The company distributes western medicines, Chinese patent medicines, healthcare products, and pharmaceutical products to downstream distributors and retail terminals. It also offers pharmaceutical product related consulting services; and operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online, make inquires and payments, etc. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and chang... [Read more]

Sector Healthcare
Founded 1984
Employees 849
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2289
Full Company Profile

Financial Performance

In 2024, Charmacy Pharmaceutical's revenue was 4.44 billion, an increase of 0.72% compared to the previous year's 4.40 billion. Earnings were 53.28 million, an increase of 3.78%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.